Table 5 Treatment outcomes of fluoropyrimidines vs. gemcitabine
| Â | F based | G based | P value |
|---|---|---|---|
Number of patients | 144 | 99 | < 0.0001 |
   With P | 83 | 94 |  |
   Without P | 61 | 5 |  |
RR (%) | 19.5 | 16.7 | 0.591 |
DCR (%) | 58.9 | 52.8 | 0.372 |
PFS (months) | 4.3 (95% CI, 3.3–5.3) | 4.0 (95% CI, 2.9–5.1) | 0.816 |
OS (months) | 9.1 (95% CI, 7.1–11.1) | 7.8 (95% CI, 6.5–9.2) | 0.848 |